Roland Wilhelm Kolbeck's most recent trade in Aclaris Therapeutics Inc was a trade of 510,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aclaris Therapeutics Inc | Roland Wilhelm Kolbeck | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 510,000 | 510,000 | - | - | Employee Stock Option (right to buy) | |
| Aclaris Therapeutics Inc | Roland Wilhelm Kolbeck | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 145,500 | 145,500 | - | - | Restricted Stock Units |